Post-authorization Safety Study in North America to Monitor Pregnancy and Infant Outcomes Following Administration of Dupilumab During Planned or Unexpected Pregnancy

Conditions

• Atopic Dermatitis (AD)
• Asthma

Interventions

• DRUG: dupilumab

Sponsor

Regeneron Pharmaceuticals

Collaborators

• [object Object]